Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bamni Proteins Limited is an Indian manufacturing company and a subsidiary of Nitta Gelatin India Limited. Established in 1997, the company specializes in the production of Ossein and Dicalcium Phosphate (DCP) derived from crushed animal bones. Ossein produced by the company is primarily exported to Japan for the manufacture of high-quality gelatin used in pharmaceutical and food applications, while Dicalcium Phosphate serves as a vital mineral additive in poultry feed. The company operates a manufacturing facility in Bamni, Maharashtra, utilizing technology provided by its parent organization. As of 2025-2026, the company has faced significant operational challenges following a regulatory closure order, leading the parent company to evaluate a potential merger or asset disposal.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bamni Proteins.